Europe Neurostimulation Devices Market By Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices) By Applications (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Neurostimulation Devices Market would witness market growth of 12.1% CAGR during the forecast period (2020-2026).
The market growth of the neurostimulation devices and the cost of devices are nevertheless expected to be reduced by side-effects such as allergic reactions or tingling or prickling of the skin. In addition, access to other treatment options such as pharmaceutical treatments and operational activities limits the market growth. Research on the use of the neurostimulators in disease management, for example, obsessive-compulsive disorders, interstitial cystitis, and asthma is instead ongoing and is expected to create profitable opportunities in future years to increase the market for neurostimulation devices.
Sacral nerve stimulators, that are used to treat chronic diseases like urinary incontinence and fecal incontinence, are predicted to be the highest CAGR. Increasing awareness of these devices is projected to be the main driver for this segment. However, the risks associated with such devices being implanted, such as mechanical failures and post-surgery pains and infections, may somewhat hinder the growth of the segment.
In the last two decades, the technological advancements in the technology have been impressive, yet the progress made in cardiovascular electrical therapy is not as significant because of the lack of funding and collaboration. Currently, neuromodulation technology is still considered to be in its infancy, but the last few years have seen some significant improvements in hardware, software, and conceptual advances to the core of the field. The long-term future will depend on innovation, investment, stabilization, and oversight by government agencies and high-level evidence.
The growth of the market for neurostimulation devices is driven by factors such as increasing the prevalence of lifestyle diseases like depression and chronic pain and increasing numbers of neurological disorders and investment in R&D. In addition, increasing demand for a minimally invasive procedure, adoption of advanced technological products, and the rise in the elderly population also stimulate market growth since they are more sensitive to neurological conditions such as Epilepsy, Parkinson's disease, Alzheimer's and chronic pain.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
The market growth of the neurostimulation devices and the cost of devices are nevertheless expected to be reduced by side-effects such as allergic reactions or tingling or prickling of the skin. In addition, access to other treatment options such as pharmaceutical treatments and operational activities limits the market growth. Research on the use of the neurostimulators in disease management, for example, obsessive-compulsive disorders, interstitial cystitis, and asthma is instead ongoing and is expected to create profitable opportunities in future years to increase the market for neurostimulation devices.
Sacral nerve stimulators, that are used to treat chronic diseases like urinary incontinence and fecal incontinence, are predicted to be the highest CAGR. Increasing awareness of these devices is projected to be the main driver for this segment. However, the risks associated with such devices being implanted, such as mechanical failures and post-surgery pains and infections, may somewhat hinder the growth of the segment.
In the last two decades, the technological advancements in the technology have been impressive, yet the progress made in cardiovascular electrical therapy is not as significant because of the lack of funding and collaboration. Currently, neuromodulation technology is still considered to be in its infancy, but the last few years have seen some significant improvements in hardware, software, and conceptual advances to the core of the field. The long-term future will depend on innovation, investment, stabilization, and oversight by government agencies and high-level evidence.
The growth of the market for neurostimulation devices is driven by factors such as increasing the prevalence of lifestyle diseases like depression and chronic pain and increasing numbers of neurological disorders and investment in R&D. In addition, increasing demand for a minimally invasive procedure, adoption of advanced technological products, and the rise in the elderly population also stimulate market growth since they are more sensitive to neurological conditions such as Epilepsy, Parkinson's disease, Alzheimer's and chronic pain.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators and
- Other Devices
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson's Disease
- Epilepsy and
- Other Applications
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corporation
- Medtronic PLC
- NeuroSigma, Inc.
- Integer Holdings Corporation
- LivaNova PLC
- NeuroPace, Inc.
- Neuronetics, Inc.
- Synapse BioMedical, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neurostimulation Devices Market, by Devices
1.4.2 Europe Neurostimulation Devices Market, by Applications
1.4.3 Europe Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 Europe Spinal Cord Stimulators Market by Country
4.2 Europe Deep Brain Stimulators Market by Country
4.3 Europe Sacral Nerve Stimulators Market by Country
4.4 Europe Vagus Nerve Stimulators Market by Country
4.5 Europe Other Devices Market by Country
CHAPTER 5. EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 Europe Pain Management Market by Country
5.2 Europe Hearing Loss Market by Country
5.3 Europe Urinary Incontinence Market by Country
5.4 Europe Parkinson's Disease Market by Country
5.5 Europe Epilepsy Market by Country
5.6 Europe Other Applications Market by Country
CHAPTER 6. EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 Germany Neurostimulation Devices Market
6.1.1 Germany Neurostimulation Devices Market by Devices
6.1.2 Germany Neurostimulation Devices Market by Applications
6.2 UK Neurostimulation Devices Market
6.2.1 UK Neurostimulation Devices Market by Devices
6.2.2 UK Neurostimulation Devices Market by Applications
6.3 France Neurostimulation Devices Market
6.3.1 France Neurostimulation Devices Market by Devices
6.3.2 France Neurostimulation Devices Market by Applications
6.4 Russia Neurostimulation Devices Market
6.4.1 Russia Neurostimulation Devices Market by Devices
6.4.2 Russia Neurostimulation Devices Market by Applications
6.5 Spain Neurostimulation Devices Market
6.5.1 Spain Neurostimulation Devices Market by Devices
6.5.2 Spain Neurostimulation Devices Market by Applications
6.6 Italy Neurostimulation Devices Market
6.6.1 Italy Neurostimulation Devices Market by Devices
6.6.2 Italy Neurostimulation Devices Market by Applications
6.7 Rest of Europe Neurostimulation Devices Market
6.7.1 Rest of Europe Neurostimulation Devices Market by Devices
6.7.2 Rest of Europe Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Neurostimulation Devices Market, by Devices
1.4.2 Europe Neurostimulation Devices Market, by Applications
1.4.3 Europe Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 Europe Spinal Cord Stimulators Market by Country
4.2 Europe Deep Brain Stimulators Market by Country
4.3 Europe Sacral Nerve Stimulators Market by Country
4.4 Europe Vagus Nerve Stimulators Market by Country
4.5 Europe Other Devices Market by Country
CHAPTER 5. EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 Europe Pain Management Market by Country
5.2 Europe Hearing Loss Market by Country
5.3 Europe Urinary Incontinence Market by Country
5.4 Europe Parkinson's Disease Market by Country
5.5 Europe Epilepsy Market by Country
5.6 Europe Other Applications Market by Country
CHAPTER 6. EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 Germany Neurostimulation Devices Market
6.1.1 Germany Neurostimulation Devices Market by Devices
6.1.2 Germany Neurostimulation Devices Market by Applications
6.2 UK Neurostimulation Devices Market
6.2.1 UK Neurostimulation Devices Market by Devices
6.2.2 UK Neurostimulation Devices Market by Applications
6.3 France Neurostimulation Devices Market
6.3.1 France Neurostimulation Devices Market by Devices
6.3.2 France Neurostimulation Devices Market by Applications
6.4 Russia Neurostimulation Devices Market
6.4.1 Russia Neurostimulation Devices Market by Devices
6.4.2 Russia Neurostimulation Devices Market by Applications
6.5 Spain Neurostimulation Devices Market
6.5.1 Spain Neurostimulation Devices Market by Devices
6.5.2 Spain Neurostimulation Devices Market by Applications
6.6 Italy Neurostimulation Devices Market
6.6.1 Italy Neurostimulation Devices Market by Devices
6.6.2 Italy Neurostimulation Devices Market by Applications
6.7 Rest of Europe Neurostimulation Devices Market
6.7.1 Rest of Europe Neurostimulation Devices Market by Devices
6.7.2 Rest of Europe Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
LIST OF TABLES
TABLE 1 EUROPE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 EUROPE SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 EUROPE DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 EUROPE SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 EUROPE PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 EUROPE PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 EUROPE EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 EUROPE EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 GERMANY NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 GERMANY NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 UK NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 UK NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 UK NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 UK NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 UK NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 UK NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 FRANCE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 FRANCE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 RUSSIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 RUSSIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 RUSSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 RUSSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 RUSSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 RUSSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 SPAIN NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 SPAIN NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 SPAIN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 62 SPAIN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 63 SPAIN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 64 SPAIN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 65 ITALY NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 ITALY NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 78 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 79 KEY INFORMATION – NEVRO CORPORATION
TABLE 80 KEY INFORMATION – MEDTRONIC PLC
TABLE 81 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 82 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 83 KEY INFORMATION – LIVANOVA PLC
TABLE 84 KEY INFORMATION – NEUROPACE, INC.
TABLE 85 KEY INFORMATION – NEURONETICS, INC.
TABLE 86 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
TABLE 1 EUROPE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 EUROPE SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 EUROPE DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 EUROPE SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 EUROPE HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 EUROPE HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 EUROPE PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 EUROPE PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 EUROPE EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 EUROPE EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 GERMANY NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 GERMANY NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 UK NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 UK NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 UK NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 UK NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 UK NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 UK NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 FRANCE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 FRANCE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 RUSSIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 RUSSIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 RUSSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 RUSSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 RUSSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 RUSSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 SPAIN NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 SPAIN NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 SPAIN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 62 SPAIN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 63 SPAIN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 64 SPAIN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 65 ITALY NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 ITALY NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 78 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 79 KEY INFORMATION – NEVRO CORPORATION
TABLE 80 KEY INFORMATION – MEDTRONIC PLC
TABLE 81 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 82 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 83 KEY INFORMATION – LIVANOVA PLC
TABLE 84 KEY INFORMATION – NEUROPACE, INC.
TABLE 85 KEY INFORMATION – NEURONETICS, INC.
TABLE 86 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
